🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Spain / NCT07385794
Active, not recruiting Not applicable

Design and Validation of a Personalized Preventive System for Adolescents Based on Biological Maturity, Body Composition, and Musculoskeletal Function.

NCT07385794 · tracked via the Priya Life Science Spain tracker
Phase
Not applicable
Started
2026-03-01
Last updated
2026-04-21

Condition(s) studied

Musculoskeletal HealthAdolescent Growth and DevelopmentInjury Prevention

Investigational drug(s) / intervention(s)

Personalized Preventive Physiotherapy and Exercise Program

Personalized Preventive Physiotherapy and Exercise Program: This intervention consists of a personalized preventive physiotherapy and exercise program designed according to each participant's biological maturation status and functional assessment. The program lasts 12 weeks and includes two supervised sessions per week. Sessions focus on neuromuscular control, strength development, mobility, balance, core stability, and postural control. The intervention is individualized based on baseline and periodic reassessments, allowing progression and adjustment throughout the program. All sessions are supervised by qualified professionals.

Study summary

This study aims to evaluate the effectiveness of a personalized preventive physiotherapy and exercise program based on biological maturation status in adolescents aged 14 to 15 years. During adolescence, rapid growth and differences in biological maturation can increase the risk of musculoskeletal imbalances, pain, and injuries, especially in physically active youth. However, most preventive programs are designed according to chronological age rather than biological development.

Participants will be assessed using non-invasive methods to determine biological maturation, body composition, and musculoskeletal function, including strength, balance, mobility, and postural control. Based on these assessments, participants in the intervention group will receive a 12-week individualized preventive physiotherapy program adapted to their maturation stage, while the control group will continue with their usual school or sports activities without structured intervention.

The study will compare changes in musculoskeletal function, body composition, pain perception, and lifestyle-related variables between baseline and post-intervention assessments. The results are expected to provide evidence for a maturation-based preventive approach that can be applied in clinical, school, and sports settings to reduce injury risk and improve musculoskeletal health in adolescents.

Eligibility

Sex
ALL
Min age
14 Years
Max age
15 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Adolescents aged 14 to 15 years at the time of enrollment. * Male and female participants. * Apparently healthy adolescents without diagnosed chronic medical conditions. * Participation in regular school physical education and/or organized sports activities. * Ability to participate in moderate physical activity as determined by a pre-participation screening. * Written informed consent obtained from parents or legal guardians, and assent from the participant. Exclusion Criteria: * Presence of acute or chronic musculoskeletal injury that limits participation in physical activity at the time of enrollment. * History of musculoskeletal surgery within the previous 12 months. * Diagnosed neurological, cardiovascular, metabolic, or systemic disease that contraindicates physical exercise. * Current participation in another structured exercise or intervention study. * Use of medication that may significantly affect musculoskeletal function or physical performance. * Any condition that, in the opinion of the investigators, could compromise participant safety or adherence to the protocol.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
European Institute of Exercise and Health Alicante Elche

More University of Alicante trials in Spain

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07385794 on ClinicalTrials.gov ↗ ← All trials in Spain